Magnus Schou

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Magnus Schou är adjungerad professor i medicinsk radiokemi vid
institutionen för klinisk neurovetenskap, Karolinska Institutet.

Artiklar

Article: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2020;59(32):13490-13495

Transition-Metal-Free Carbon Isotope Exchange of Phenyl Acetic Acids.

Destro G; Horkka K; Loreau O; Buisson D-A; Kingston L; Del Vecchio A; Schou M; Elmore CS; Taran F; Cantat T; Audisio D
Article: ACS CHEMICAL NEUROSCIENCE. 2020;11(12):1756-1761

Synthesis and Preclinical Evaluation of 6-[18F]Fluorine-α-methyl-l-tryptophan, a Novel PET Tracer for Measuring Tryptophan Uptake.

Krasikova R; Kondrashov M; Avagliano C; Petukhov M; Vazquez-Romero A; Revunov E; Johnström P; Tari L; Tóth M; Häggkvist J; Erhardt S; Cervenka S; Schou M
Article: EJNMMI RESEARCH. 2020;10(1):59

Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung - a test-retest PET study in control subjects.

Cselényi Z; Jucaite A; Kristensson C; Stenkrona P; Ewing P; Varrone A; Johnström P; Schou M; Vazquez-Romero A; Moein MM; Bolin M; Siikanen J; Grybäck P; Larsson B; Halldin C; Grime K; Eriksson UG; Farde L
Article: ACS CHEMICAL NEUROSCIENCE. 2020;11(9):1245-1249

First Radiolabeling of a Ganglioside with a Positron Emitting Radionuclide: In Vivo PET Demonstrates Low Exposure of Radiofluorinated GM1 in Non-human Primate Brain.

Revunov E; Johnström P; Arakawa R; Malmquist J; Jucaite A; Defay T; Takano A; Schou M
Article: ACS CHEMICAL NEUROSCIENCE. 2020;11(7):1048-1057

Synthesis, Biodistribution, and Radiation Dosimetry of a Novel mGluR5 Radioligand: 18F-AZD9272.

Nag S; Varnäs K; Arakawa R; Jahan M; Schou M; Farde L; Halldin C
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2020;40(4):799-807

A PET study in healthy subjects of brain exposure of 11C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancer.

Varrone A; Varnäs K; Jucaite A; Cselényi Z; Johnström P; Schou M; Vazquez-Romero A; Moein MM; Halldin C; Brown AP; Vishwanathan K; Farde L
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2020;63(3):100-107

"In-loop" carbonylation-A simplified method for carbon-11 labelling of drugs and radioligands.

Ferrat M; Dahl K; Halldin C; Schou M
Article: JOURNAL OF ORGANIC CHEMISTRY. 2019;84(24):16076-16085

Visible-Light-Enabled Aminocarbonylation of Unactivated Alkyl Iodides with Stoichiometric Carbon Monoxide for Application on Late-Stage Carbon Isotope Labeling.

Sardana M; Bergman J; Ericsson C; Kingston LP; Schou M; Dugave C; Audisio D; Elmore CS
Article: EJNMMI RESEARCH. 2019;9(1):100

Potential for imaging the high-affinity state of the 5-HT1B receptor: a comparison of three PET radioligands with differing intrinsic activity.

Lindberg A; Arakawa R; Nogami T; Nag S; Schou M; Elmore CS; Farde L; Pike VW; Halldin C
Article: NUCLEAR MEDICINE AND BIOLOGY. 2019;78-79:11-16

Development of a 18F-labeled PET radioligand for imaging 5-HT1B receptors: [18F]AZ10419096.

Lindberg A; Nag S; Schou M; Arakawa R; Nogami T; Moein MM; Elmore CS; Pike VW; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2019;62(6):265-279

Synthesis, 3 H-labelling and in vitro evaluation of a substituted dipiperidine alcohol as a potential ligand for chemokine receptor 2.

Artelsmair M; Miranda-Azpiazu P; Kingston L; Bergare J; Schou M; Varrone A; Elmore CS
Article: NUCLEAR MEDICINE AND BIOLOGY. 2019;70:1-13

Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors.

Lindberg A; Lu S; Nag S; Schou M; Liow J-S; Zoghbi SS; Frankland MP; Gladding RL; Morse CL; Takano A; Amini N; Elmore CS; Lee YS; Innis RB; Halldin C; Pike VW
Article: CHEMISTRYSELECT. 2019;4(6):1846-1849

Rapid and Efficient Synthesis of ¹¹C-Labeled Benzimidazolones Using [¹¹C]Carbon Dioxide

Horkka K; Dahl K; Bergare J; Elmore CS; Halldin C; Schou M
Article: EJNMMI RESEARCH. 2019;9(1):9

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator.

Schou M; Ewing P; Cselenyi Z; Fridén M; Takano A; Halldin C; Farde L
Article: EJNMMI RESEARCH. 2018;8(1):113

The development of a GPR44 targeting radioligand [11C]AZ12204657 for in vivo assessment of beta cell mass.

Jahan M; Johnström P; Selvaraju RK; Svedberg M; Winzell MS; Bernström J; Kingston L; Schou M; Jia Z; Skrtic S; Johansson L; Korsgren O; Farde L; Halldin C; Eriksson O
Article: ACS CHEMICAL NEUROSCIENCE. 2018;9(11):2542-2547

Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy.

Cairns AG; Vazquez-Romero A; Mahdi Moein M; Ådén J; Elmore CS; Takano A; Arakawa R; Varrone A; Almqvist F; Schou M
Article: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2018;57(31):9744-9748

Late-Stage Isotopic Carbon Labeling of Pharmaceutically Relevant Cyclic Ureas Directly from CO2.

Del Vecchio A; Caillé F; Chevalier A; Loreau O; Horkka K; Halldin C; Schou M; Camus N; Kessler P; Kuhnast B; Taran F; Audisio D
Article: ACS CHEMICAL NEUROSCIENCE. 2018;9(5):906-911

Development of [ Carbonyl-11C]AZ13198083, a Novel Histamine Type-3 Receptor Radioligand with Favorable Kinetics.

Dahl K; Nakao R; Amini N; Moein MM; Finnema S; Malmquist J; Varnäs K; Schou M
Article: CHEMICAL COMMUNICATIONS. 2018;54(34):4286-4289

[18F]fluoro-benziodoxole: a no-carrier-added electrophilic fluorinating reagent. Rapid, simple radiosynthesis, purification and application for fluorine-18 labelling.

Cortés González MA; Nordeman P; Bermejo Gómez A; Meyer DN; Antoni G; Schou M; Szabó KJ
Article: ACS CHEMICAL NEUROSCIENCE. 2018;9(2):224-229

Discovery of a Novel Muscarinic Receptor PET Radioligand with Rapid Kinetics in the Monkey Brain.

Malmquist J; Varnäs K; Svedberg M; Vallée F; Albert JS; Finnema SJ; Schou M
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2017;60(13):624-628

Reduction of [11 C]CO2 to [11 C]CO using solid supported zinc.

Dahl K; Ulin J; Schou M; Halldin C
Article: NUCLEAR MEDICINE AND BIOLOGY. 2017;54:34-40

[11C]AZ10419096 - a full antagonist PET radioligand for imaging brain 5-HT1B receptors.

Lindberg A; Nag S; Schou M; Takano A; Matsumoto J; Amini N; Elmore CS; Farde L; Pike VW; Halldin C
Article: JOURNAL OF FLUORINE CHEMISTRY. 2017;194:51-57

Synthesis of trifluoromethyl moieties by late-stage copper (I) mediated nucleophilic fluorination

Gome AB; Gonzalez MAC; Lubcke M; Johansson MJ; Schou M; Szabo KJ
Article: CHEMICAL COMMUNICATIONS. 2016;52(97):13963-13966

Efficient DBU accelerated synthesis of 18F-labelled trifluoroacetamides.

Gómez AB; Cortés González MA; Lübcke M; Johansson MJ; Halldin C; Szabó KJ; Schou M
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2016;358(3):464-471

Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676.

Varnäs K; Juréus A; Johnström P; Ahlgren C; Schött P; Schou M; Gruber S; Jerning E; Malmborg J; Halldin C; Afzelius L; Farde L
Article: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY. 2016;2016(16):2775-2777

Direct and Efficient (Carbonyl)cobalt-Mediated Aryl Acetylation Using [¹¹C] Methyl Iodide

Dahl K; Schou M; Halldin C
Article: ACS CHEMICAL NEUROSCIENCE. 2016;7(2):177-184

Discovery and Preclinical Validation of [(11)C]AZ13153556, a Novel Probe for the Histamine Type 3 Receptor.

Schou M; Varnäs K; Jureus A; Ahlgren C; Malmquist J; Häggkvist J; Tari L; Wesolowski SS; Throner SR; Brown DG; Nilsson M; Johnström P; Finnema SJ; Nakao R; Amini N; Takano A; Farde L
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2015;58(5):220-225

An evaluation of a high-pressure (11)CO carbonylation apparatus.

Dahl K; Itsenko O; Rahman O; Ulin J; Sjöberg C-O; Sandblom P; Larsson L-A; Schou M; Halldin C
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2015;18(10):pyv036

Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates.

Schou M; Varnäs K; Lundquist S; Nakao R; Amini N; Takano A; Finnema SJ; Halldin C; Farde L
Article: RSC ADVANCES. 2015;5(108):88886-88889

¹¹C-carbonylation reactions using gas-liquid segmented microfluidics

Dahl K; Schou M; Ulin J; Sjoberg C-O; Farde L; Halldin C
Article: EJNMMI RESEARCH. 2014;4(1):50-8

Identification of positron emission tomography (PET) tracer candidates by prediction of the target-bound fraction in the brain.

Fridén M; Wennerberg M; Antonsson M; Sandberg-Ställ M; Farde L; Schou M
Article: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2014;98:140-143

Determination of plasma protein binding of positron emission tomography radioligands by high-performance frontal analysis.

Amini N; Nakao R; Schou M; Halldin C
Article: MOLECULAR IMAGING AND BIOLOGY. 2014;16(2):173-179

Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primates.

Schou M; Varnäs K; Sandell J; Johnström P; Cselenyi Z; Svensson S; Nakao R; Amini N; Bergman L; Sumic A; Gulyas B; Lindström-Böö E; Halldin C; Farde L
Article: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY. 2014;2014(2):307-310

Improved Yields for the Palladium-Mediated ¹¹C-Carbonylation Reaction Using Microwave Technology

Dahl K; Schou M; Rahman O; Halldin C
Article: NUCLEAR MEDICINE AND BIOLOGY. 2013;40(3):410-414

Radiolabeling of the cannabinoid receptor agonist AZD1940 with carbon-11 and PET microdosing in non-human primate.

Schou M; Varnäs K; Jucaite A; Gulyás B; Halldin C; Farde L
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2013;40(4):580-593

Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.

Forsberg A; Juréus A; Cselényi Z; Eriksdotter M; Freund-Levi Y; Jeppsson F; Swahn B-M; Sandell J; Julin P; Schou M; Andersson J; Johnström P; Varnäs K; Halldin C; Farde L; Svensson S
Article: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY. 2013;2013(7):1228-1231

Palladium-Mediated [¹¹C]Carbonylation at Atmospheric Pressure: A General Method Using Xantphos as Supporting Ligand

Dahl K; Schou M; Amini N; Halldin C
Article: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2013;405(4):1303-1310

Identification of PET radiometabolites by cytochrome P450, UHPLC/Q-ToF-MS and fast radio-LC: applied to the PET radioligands [11C]flumazenil, [18F]FE-PE2I, and [11C]PBR28.

Amini N; Nakao R; Schou M; Halldin C
Article: JOURNAL OF CHROMATOGRAPHY A. 2012;1266:76-83

Rapid metabolite analysis of positron emission tomography radioligands by direct plasma injection combining micellar cleanup with high submicellar liquid chromatography with radiometric detection.

Nakao R; Schou M; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2012;55(13):460-462

Radiolabeling of two 11C-labeled formylating agents and their application in the preparation of [11C]benzimidazole

Schou M; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2012;55(13):455-459

Radiofluorination and reductive amination using a microfluidic device

Dahl K; Schou M; Halldin C
Article: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 2012;22(13):4332-4337

Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as ¹⁸F-PET imaging agents for β-amyloid plaques.

Swahn B-M; Sandell J; Pyring D; Bergh M; Jeppsson F; Juréus A; Neelissen J; Johnström P; Schou M; Svensson S
Article: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2012;895-896:116-122

Rapid and sensitive measurement of PET radioligands in plasma by fast liquid chromatography/radiometric detection.

Nakao R; Schou M; Halldin C
Article: ANALYTICAL CHEMISTRY. 2012;84(7):3222-3230

Direct plasma metabolite analysis of positron emission tomography radioligands by micellar liquid chromatography with radiometric detection.

Nakao R; Schou M; Halldin C
Article: JOURNAL OF NUCLEAR MEDICINE. 2012;53(3):415-424

Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand.

Cselényi Z; Jönhagen ME; Forsberg A; Halldin C; Julin P; Schou M; Johnström P; Varnäs K; Svensson S; Farde L
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2011;54(14):847-854

Synthesis of a delta opioid agonist in [2H6], [2H4], [11C], and [14C] labeled forms

Elmore CS; Brush K; Schou M; Palmer W; Dorff PN; Powell ME; Hoesch V; Hall JE; Hudzik T; Halldin C; Dantzman CL
Article: SYNAPSE. 2009;63(10):871-880

In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.

Varrone A; Steiger C; Schou M; Takano A; Finnema SJ; Guilloteau D; Gulyás B; Halldin C
Article: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 2009;19(16):4843-4845

Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter.

Schou M; Steiger C; Varrone A; Guilloteau D; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2009;52(5-6):158-165

A two-step one-pot radiosynthesis of the potent dopamine D₂/D₃ agonist PET radioligand [¹¹C]MNPA

Steiger C; Finnema SJ; Raus L; Schou M; Nakao R; Suzuki K; Pike VW; Wikstrom HV; Halldin C
Article: MOLECULAR IMAGING AND BIOLOGY. 2009;11(1):23-30

Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats.

Schou M; Zoghbi SS; Shetty HU; Shchukin E; Liow J-S; Hong J; Andrée BA; Gulyás B; Farde L; Innis RB; Pike VW; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2008;51(3-4):146-152

Radiolabeling of a high potency cannabinoid subtype-1 receptor ligand, N-(4-fluoro-benzyl)-4-(3-(piperidin-1-yl)-indole-1-sulfonyl)benzamide (PipISB), with carbon-11 or fluorine-18

Donohue SR; Halldin C; Schou M; Hong J; Phebus L; Chernet E; Hitchcock SA; Gardinier KM; Ruley KM; Krushinski JH; Schaus J; Pike VW
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2008;35(3):630-636

Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[18F]FMeNER-D2: a human whole-body PET study.

Takano A; Halldin C; Varrone A; Karlsson P; Sjöholm N; Stubbs JB; Schou M; Airaksinen AJ; Tauscher J; Gulyás B
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2008;35(1):153-157

Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[18F]FMeNER-D2.

Takano A; Gulyás B; Varrone A; Karlsson P; Schou M; Airaksinen AJ; Vandenhende F; Tauscher J; Halldin C
Article: APPLIED RADIATION AND ISOTOPES. 2007;65(3):293-300

Synthesis of 3H-labeled N-(3-iodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(4-methylphenyl)nortropane (PE2I) and its interaction with mice striatal membrane fragments.

Stepanov V; Schou M; Järv J; Halldin C
Article: BIOORGANIC & MEDICINAL CHEMISTRY. 2007;15(2):616-625

Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.

Schou M; Pike VW; Sóvágó J; Gulyás B; Gallagher PT; Dobson DR; Walter MW; Rudyk H; Farde L; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2006;49(11):1007-1019

Synthesis and PET evaluation of (R)-[S-methyl-¹¹C]thionisoxetine, a candidate radioligand for imaging brain norepinephrine transporters

Schou M; Pike VW; Varrone A; Gulyas B; Farde L; Halldin C
Article: PSYCHOPHARMACOLOGY. 2006;188(1):119-127

Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.

Seneca N; Gulyás B; Varrone A; Schou M; Airaksinen A; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
Article: MOLECULAR IMAGING AND BIOLOGY. 2006;8(1):1-8

Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands: [C-11]desipramine, [C-11]talopram and [C-11]talsupram.

Schou M; Sóvágó J; Pike VW; Gulyás B; Bøgesø KP; Farde L; Halldin C
Article: BRAIN RESEARCH BULLETIN. 2005;67(3):219-224

Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [11C]RGH-1756.

Sóvágó J; Farde L; Halldin C; Schukin E; Schou M; Laszlovszky I; Kiss B; Gulyás B
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2005;15(5):517-520

Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2.

Schou M; Halldin C; Pike VW; Mozley PD; Dobson D; Innis RB; Farde L; Hall H
Article: NUCLEAR MEDICINE COMMUNICATIONS. 2005;26(8):695-700

Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primates.

Seneca N; Andree B; Sjoholm N; Schou M; Pauli S; Mozley PD; Stubbs JB; Liow J-S; Sovago J; Gulyás B; Innis R; Halldin C
Article: SYNAPSE. 2005;56(2):100-104

Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters.

Ghose S; Fujita M; Morrison P; Uhl G; Murphy DL; Mozley PD; Schou M; Halldin C; Innis R
Article: JOURNAL OF ORGANIC CHEMISTRY. 2004;69(25):8694-8701

A total synthesis of hydroxylysine in protected form and investigations of the reductive opening of p-methoxybenzylidene acetals.

Gustafsson T; Schou M; Almqvist F; Kihlberg J
Article: SYNAPSE. 2004;53(2):57-67

PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain.

Schou M; Halldin C; Sóvágó J; Pike VW; Hall H; Gulyás B; Mozley PD; Dobson D; Shchukin E; Innis RB; Farde L
Article: NUCLEAR MEDICINE AND BIOLOGY. 2003;30(7):707-714

Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER.

Schou M; Halldin C; Sóvágó J; Pike VW; Gulyás B; Mozley PD; Johnson DP; Hall H; Innis RB; Farde L
Visa fler

Alla övriga publikationer

Review: TRAC-TRENDS IN ANALYTICAL CHEMISTRY. 2019;110:1-7

Sample preparation techniques for radiometabolite analysis of positron emission tomography radioligands; trends, progress, limitations and future prospects

Moein MM; Nakao R; Amini N; Abdel-Rehim M; Schou M; Halldin C
Review: CLINICAL AND TRANSLATIONAL IMAGING. 2017;5(3):291-298

PET microdosing of CNS drugs

Schou M; Varnas K
Review: CLINICAL AND TRANSLATIONAL IMAGING. 2017;5(3):275-289

New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals.

Dahl K; Halldin C; Schou M
Review: CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2007;7(18):1806-1816

Development of radioligands for imaging of brain norepinephrine transporters in vivo with positron emission tomography.

Schou M; Pike VW; Halldin C

Anställningar

Adjungerad Professor, Klinisk neurovetenskap, Karolinska Institutet, 2022-2026

Examina och utbildning

Docent, Medicinsk strålningsbiologi, Karolinska Institutet, 2020
MEDICINE DOKTORSEXAMEN, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2006

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI